keyword
MENU ▼
Read by QxMD icon Read
search

Leucemia

keyword
https://www.readbyqxmd.com/read/27513487/-not-available
#1
Elena Guadalupe Corella Aznar, Ariadna Ayerza Casas, Pilar Samper Villagrasa, Carmen Rodríguez Vigil, Lorenzo Jiménez Montañés, Carlota Calvo Escribano, José Ignacio Labarta Aizpun
Introducción: los supervivientes de leucemia aguda (LA) infantil presentan un riesgo incrementado de alteraciones metabólicas y cardiovasculares que aumentan su morbimortalidad a largo plazo.Objetivo: estimar la prevalencia de obesidad, resistencia a la insulina, dislipemia e hipertensión arterial como factores de riesgo cardiometabólico (FRCM) en un grupo de supervivientes de LA infantil, y analizar las posibles causas asociadas a su desarrollo.Material y métodos: estudio observacional retrospectivo en 47 supervivientes de LA tratados en un periodo de 4 años, que recibieron seguimiento durante 10 años...
2016: Nutrición Hospitalaria: Organo Oficial de la Sociedad Española de Nutrición Parenteral y Enteral
https://www.readbyqxmd.com/read/27444459/-not-available
#2
Elena Guadalupe Corella Aznar, Ariadna Ayerza Casas, Pilar Samper Villagrasa, Carmen Rodríguez Vigil, Lorenzo Jiménez Montañés, Carlota Calvo Escribano, José Ignacio Labarta Aizpun
Introducción: los supervivientes de leucemia aguda (LA) infantil presentan un riesgo incrementado de alteraciones metabólicas y cardiovasculares que aumentan su morbimortalidad a largo plazo.Objetivo: estimar la prevalencia de obesidad, resistencia a la insulina, dislipemia e hipertensión arterial como factores de riesgo cardiometabólico (FRCM) en un grupo de supervivientes de LA infantil, y analizar las posibles causas asociadas a su desarrollo.Material y métodos: estudio observacional retrospectivo en 47 supervivientes de LA tratados en un periodo de 4 años, que recibieron seguimiento durante 10 años...
2016: Nutrición Hospitalaria: Organo Oficial de la Sociedad Española de Nutrición Parenteral y Enteral
https://www.readbyqxmd.com/read/27135630/dose-dependent-protective-effect-of-baicalin-against-testicular-torsion-detorsion-in-rats
#3
A A Fouad, H O Qutub, I Jresat
Testicular torsion/detorsion induces oxidative/nitrosative stress, inflammation and apoptosis of testicular tissues. Baicalin exerts antioxidant and anti-inflammatory properties. This study investigated the possible protective effect of baicalin against testicular torsion-detorsion injury in rats. Surgical testicular torsion was induced for 2 h, followed by detorsion which was continued for 24 h. Baicalin was administered in three different doses (25, 50 and 100 mg kg(-1) , by intraperitoneal injection)...
May 2, 2016: Andrologia
https://www.readbyqxmd.com/read/26630574/a-low-frequency-of-losses-in-11q-chromosome-is-associated-with-better-outcome-and-lower-rate-of-genomic-mutations-in-patients-with-chronic-lymphocytic-leukemia
#4
José Ángel Hernández, María Hernández-Sánchez, Ana Eugenia Rodríguez-Vicente, Vera Grossmann, Rosa Collado, Cecilia Heras, Anna Puiggros, Ana África Martín, Noemí Puig, Rocío Benito, Cristina Robledo, Julio Delgado, Teresa González, José Antonio Queizán, Josefina Galende, Ignacio de la Fuente, Guillermo Martín-Núñez, José María Alonso, Pau Abrisqueta, Elisa Luño, Isabel Marugán, Isabel González-Gascón, Francesc Bosch, Alexander Kohlmann, Marcos González, Blanca Espinet, Jesús María Hernández-Rivas
To analyze the impact of the 11q deleted (11q-) cells in CLL patients on the time to first therapy (TFT) and overall survival (OS), 2,493 patients with CLL were studied. 242 patients (9.7%) had 11q-. Fluorescence in situ hybridization (FISH) studies showed a threshold of 40% of deleted cells to be optimal for showing that clinical differences in terms of TFT and OS within 11q- CLLs. In patients with ≥40% of losses in 11q (11q-H) (74%), the median TFT was 19 months compared with 44 months in CLL patients with <40% del(11q) (11q-L) (P<0...
2015: PloS One
https://www.readbyqxmd.com/read/26603004/outcome-of-children-and-adolescents-with-lymphoblastic-lymphoma
#5
Maria Christina Lopes Araújo Oliveira, Keyla Christy Sampaio, Aline Carneiro Oliveira, Aieska Dantas Santos, Lúcia Porto Castro, Marcos Borato Viana
INTRODUCTION: lymphoblastic lymphoma (LBL) is the second most common subtype of non-Hodgkin lymphoma in children. The aim of this study was to characterize the clinical course of children and adolescents with LBL treated at a tertiary center. METHODS: this is a retrospective cohort study of 27 patients aged 16 years or younger with LBL admitted between January 1981 and December 2013. Patients were treated according to the therapy protocol used for acute lymphoblastic leucemia...
September 2015: Revista da Associação Médica Brasileira
https://www.readbyqxmd.com/read/26190424/acute-lymphoblastic-leukemia-in-children-and-adolescents-prognostic-factors-and-analysis-of-survival
#6
Daniel Willian Lustosa de Sousa, Francisco Valdeci de Almeida Ferreira, Francisco Helder Cavalcante Félix, Marcos Vinicios de Oliveira Lopes
OBJECTIVE: To describe the clinical and laboratory features of children and adolescents with acute lymphoblastic leukemia treated at three referral centers in Ceará and evaluate prognostic factors for survival, including age, gender, presenting white blood cell count, immunophenotype, DNA index and early response to treatment. METHODS: Seventy-six under 19-year-old patients with newly diagnosed acute lymphoblastic leukemia treated with the Grupo Brasileiro de Tratamento de Leucemia da Infância - acute lymphoblastic leukemia-93 and -99 protocols between September 2007 and December 2009 were analyzed...
July 2015: Revista Brasileira de Hematologia e Hemoterapia
https://www.readbyqxmd.com/read/25946529/-depression-in-school-children-and-adolescents-carriers-of-acute-leukemia-during-the-treatment-phase
#7
COMPARATIVE STUDY
Nancy Susana Rivas-Molina, Edgar Omar Mireles-Pérez, Janet Margarita Soto-Padilla, Nora Adriana González-Reyes, Tanya Lizbeth Barajas-Serrano, Juan Carlos Barrera de León
UNLABELLED: Objective: To describe depression levels in school aged children and adolescents with acute leukemia during the treatment. MATERIALS AND METHODS: This transversal descriptive study took place during January to September 2012 and included school aged children and adolescents, carriers of acute leukemia, in treatment at a high-ranking specialty hospital. A modified Kovacs questionnaire (C O/) was applied. They were grouped according to presence or absence of depression...
March 2015: Gaceta Médica de México
https://www.readbyqxmd.com/read/25946524/-analysis-of-clinical-biological-features-of-adult-acute-lymphoblastic-leukemia
#8
Rosbiney Díaz-Ruiz, Lilia Aguilar-López, Arturo Vega-Ruiz, Oscar Garcés-Ruiz, Arnulfo Nava-Zavala, Benjamín Rubio-Jurado
INTRODUCCTION: Acute lymphoblastic leukemia (ALL) is a clonal disease characterized by a proliferation of immature cells. In immunophenotypic, cytogenetic and molecular studies, it is a heterogeneous disease with diverse manifestations and prognoses. The treatment is complex and is associated with complications during its course. PATIENTS AND METHODS: A prospective study of cohort of patients with ALL. Subjects were recruited consecutively from April 2010 to November 2012 in the Specialties Hospital, /MSS...
March 2015: Gaceta Médica de México
https://www.readbyqxmd.com/read/25689772/a-high-proportion-of-cells-carrying-trisomy-12-is-associated-with-a-worse-outcome-in-patients-with-chronic-lymphocytic-leukemia
#9
Isabel González-Gascón Y Marín, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Carmen Sanzo, Anna Aventín, Anna Puiggros, Rosa Collado, Cecilia Heras, Carolina Muñoz, Julio Delgado, Margarita Ortega, María-Teresa González, Isabel Marugán, Ignacio de la Fuente, Isabel Recio, Francesc Bosch, Blanca Espinet, Marcos González, Jesús-María Hernández-Rivas, José-Ángel Hernández
The prognosis of chronic lymphocytic leukemia (CLL) patients displaying trisomy 12 (+12) remains unclear. In this study, we analyzed the influence of the proportion of cells with +12, and other clinical and biologic factors, in time to first therapy (TTFT) and overall survival (OS), in 289 patients diagnosed with CLL carrying +12. Median OS was 129 months. One hundred seventy-four patients (60.2%) presented +12 in <60% of cells. TTFT and OS for this subgroup were longer than for the subgroup with +12 in ≥60% of cells, with a median TTFT of 49 months (CI95%, 39-58) vs 30 months (CI95%, 22-38) (P = 0...
June 2016: Hematological Oncology
https://www.readbyqxmd.com/read/24915757/interstitial-13q14-deletions-detected-in-the-karyotype-and-translocations-with-concomitant-deletion-at-13q14-in-chronic-lymphocytic-leukemia-different-genetic-mechanisms-but-equivalent-poorer-clinical-outcome
#10
MULTICENTER STUDY
Anna Puiggros, Marta Venturas, Marta Salido, Gonzalo Blanco, Concepción Fernandez-Rodriguez, Rosa Collado, Alberto Valiente, Neus Ruiz-Xivillé, Ana Carrió, Francisco José Ortuño, Elisa Luño, María José Calasanz, María Teresa Ardanaz, María Ángeles Piñán, Elisabet Talavera, María Teresa González, Margarita Ortega, Isabel Marugán, Ana Ferrer, Eva Gimeno, Beatriz Bellosillo, Julio Delgado, José Ángel Hernández, Jesús María Hernández-Rivas, Blanca Espinet
Deletion of 13q14 as the sole abnormality is a good prognostic marker in chronic lymphocytic leukemia (CLL). Nonetheless, the prognostic value of reciprocal 13q14 translocations [t(13q)] with related 13q losses has not been fully elucidated. We described clinical and biological characteristics of 25 CLL patients with t(13q), and compared with 62 patients carrying interstitial del(13q) by conventional G-banding cytogenetics (CGC) [i-del(13q)] and 295 patients with del(13q) only detected by fluorescence in situ hybridization (FISH) [F-del(13q)]...
September 2014: Genes, Chromosomes & Cancer
https://www.readbyqxmd.com/read/24824767/multilineage-dysplasia-is-associated-with-a-poorer-prognosis-in-patients-with-de-novo-acute-myeloid-leukemia-with-intermediate-risk-cytogenetics-and-wild-type-npm1
#11
COMPARATIVE STUDY
María Rozman, José-Tomás Navarro, Leonor Arenillas, Anna Aventín, Teresa Giménez, Esther Alonso, Granada Perea, Mireia Camós, Mayda Navarrete, Esperanza Tuset, Lourdes Florensa, Fuensanta Millá, Josep Nomdedéu, Esmeralda de la Banda, Marina Díaz-Beyá, Marta Pratcorona, Ana Garrido, Blanca Navarro, Salut Brunet, Jorge Sierra, Jordi Esteve
Acute myeloid leukemia (AML) with myelodysplasia-related changes is characterized by the presence of multilineage dysplasia (MLD), frequently related to high-risk cytogenetics and poor outcome. However, the presence of MLD does not modify the favorable prognostic impact of NPM1 mutation. The prognosis of patients with AML presenting marked dysplasia lacking high-risk cytogenetics and NPM1 mutation is uncertain. We evaluated the prognostic impact of MLD in 177 patients with intermediate-risk cytogenetics AML (IR-AML) and wild-type NPM1...
October 2014: Annals of Hematology
https://www.readbyqxmd.com/read/24072101/microrna-expression-at-diagnosis-adds-relevant-prognostic-information-to-molecular-categorization-in-patients-with-intermediate-risk-cytogenetic-acute-myeloid-leukemia
#12
M Díaz-Beyá, S Brunet, J Nomdedéu, R Tejero, T Díaz, M Pratcorona, M Tormo, J M Ribera, L Escoda, R Duarte, D Gallardo, I Heras, M P Queipo de Llano, J Bargay, M Monzo, J Sierra, A Navarro, J Esteve
Acute myeloid leukemia (AML) is a heterogeneous disease, and optimal treatment varies according to cytogenetic risk factors and molecular markers. Several studies have demonstrated the prognostic importance of microRNAs (miRNAs) in AML. Here we report a potential association between miRNA expression and clinical outcome in 238 intermediate-risk cytogenetic AML (IR-AML) patients from 16 institutions in the CETLAM cooperative group. We first profiled 670 miRNAs in a subset of 85 IR-AML patients from a single institution and identified 10 outcome-related miRNAs...
April 2014: Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
https://www.readbyqxmd.com/read/23869550/biallelic-losses-of-13q-do-not-confer-a-poorer-outcome-in-chronic-lymphocytic-leukaemia-analysis-of-627-patients-with-isolated-13q-deletion
#13
Anna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, Rosa Collado, Anna Aventín, Elisa Luño, Javier Grau, José Ángel Hernandez, Isabel Marugán, Maite Ardanaz, Teresa González, Alberto Valiente, Mar Osma, Maria José Calasanz, Carmen Sanzo, Ana Carrió, Margarita Ortega, Rodrigo Santacruz, Pau Abrisqueta, Eugènia Abella, Francesc Bosch, Félix Carbonell, Francesc Solé, Jesús Maria Hernández, Blanca Espinet
Losses in 13q as a sole abnormality confer a good prognosis in chronic lymphocytic leukaemia (CLL). Nevertheless, its heterogeneity has been demonstrated and the clinical significance of biallelic 13q deletions remains controversial. We compared the clinico-biological characteristics of a series of 627 patients harbouring isolated 13q deletions by fluorescence in situ hybridization (FISH), either monoallelic (13q × 1), biallelic (13q × 2), or the coexistence of both clones (13qM). The most frequent 13q deletion was 13q × 1 (82·1%), while 13q × 2 and 13qM represented 8·6% and 9·3% of patients respectively...
October 2013: British Journal of Haematology
https://www.readbyqxmd.com/read/23830547/-national-guidelines-for-the-management-of-patients-with-chronic-lymphocytic-leukemia-sociedad-espan%C3%AB-ola-de-hematolog%C3%A4-%C3%A2-a-y-hemoterapia-and-grupo-espan%C3%AB-ol-de-leucemia-linfoc%C3%A4-%C3%A2-tica-cro%C3%A2-nica
#14
José A García Marco, Pilar Giraldo Castellano, Javier López Jiménez, Eduardo Ríos Herranz, José Luis Sastre Moral, M José Terol Casterá, Francesc Bosch Albareda
Chronic lymphocytic leukemia is the most common chronic lymphoproliferative disorder in Spain. The clinical management of this entity varies widely. Currently, in Spain, there are no national consensus guidelines, such as those published in other countries, to guide the diagnosis and treatment of this malignancy and the use of prognostic scores. This article reviews the current scientific literature and addresses issues on the diagnosis of chronic lymphocytic leukemia, the spread of the disease, the presence of comorbidities, the classification of prognostic scores, the common treatment regimens stratified by risk factors, and the management of complications associated with both the disease and its treatment, as well as the various controversies related to this entity...
August 17, 2013: Medicina Clínica
https://www.readbyqxmd.com/read/23377436/favorable-outcome-of-patients-with-acute-myeloid-leukemia-harboring-a-low-allelic-burden-flt3-itd-mutation-and-concomitant-npm1-mutation-relevance-to-post-remission-therapy
#15
Marta Pratcorona, Salut Brunet, Josep Nomdedéu, Josep Maria Ribera, Mar Tormo, Rafael Duarte, Lourdes Escoda, Ramon Guàrdia, M Paz Queipo de Llano, Olga Salamero, Joan Bargay, Carmen Pedro, Josep Maria Martí, Montserrat Torrebadell, Marina Díaz-Beyá, Mireia Camós, Dolors Colomer, Montserrat Hoyos, Jorge Sierra, Jordi Esteve
Risk associated to FLT3 internal tandem duplication (FLT3-ITD) in patients with acute myeloid leukemia (AML) may depend on mutational burden and its interaction with other mutations. We analyzed the effect of FLT3-ITD/FLT3 wild-type (FLT3wt) ratio depending on NPM1 mutation (NPM1mut) in 303 patients with intermediate-risk cytogenetics AML treated with intensive chemotherapy. Among NPM1mut patients, FLT3wt and low ratio (<0.5) subgroups showed similar overall survival, relapse risk, and leukemia-free survival, whereas high ratio (≥0...
April 4, 2013: Blood
https://www.readbyqxmd.com/read/23323068/incidence-and-risk-factors-for-central-nervous-system-relapse-in-children-and-adolescents-with-acute-lymphoblastic-leukemia
#16
Camila Silva Peres Cancela, Mitiko Murao, Marcos Borato Viana, Benigna Maria de Oliveira
BACKGROUND: Despite all the advances in the treatment of childhood acute lymphoblastic leukemia, central nervous system relapse remains an important obstacle to curing these patients. This study analyzed the incidence of central nervous system relapse and the risk factors for its occurrence in children and adolescents with acute lymphoblastic leukemia. METHODS: This study has a retrospective cohort design. The studied population comprised 199 children and adolescents with a diagnosis of acute lymphoblastic leukemia followed up at Hospital das Clinicas, Universidade Federal de Minas Gerais (HC-UFMG) between March 2001 and August 2009 and submitted to the Grupo Brasileiro de Tratamento de Leucemia da Infância - acute lymphoblastic leukemia (GBTLI-LLA-99) treatment protocol...
2012: Revista Brasileira de Hematologia e Hemoterapia
https://www.readbyqxmd.com/read/22224845/chronic-lymphocytic-leukaemia-with-17p-deletion-a-retrospective-analysis-of-prognostic-factors-and-therapy-results
#17
MULTICENTER STUDY
Julio Delgado, Blanca Espinet, Ana C Oliveira, Pau Abrisqueta, Javier de la Serna, Rosa Collado, Javier Loscertales, Montserrat Lopez, Jose A Hernandez-Rivas, Christelle Ferra, Angel Ramirez, Josep M Roncero, Cristina Lopez, Anna Aventin, Anna Puiggros, Eugenia Abella, Felix Carbonell, Dolors Costa, Anna Carrio, Marcos Gonzalez
Patients with chronic lymphocytic leukaemia (CLL) whose tumour cells harbour a 17p deletion (17p-) are universally considered to have a poor prognosis. The deletion can be detected at diagnosis or during the evolution of the disease, particularly in patients who have received chemotherapy. We sought to evaluate the natural history of patients with 17p- CLL, identify predictive factors within this prognostic subgroup, and evaluate the results of different therapeutic approaches. Data from 294 patients with 17p- CLL followed up at 20 different institutions was retrospectively collected and analysed...
April 2012: British Journal of Haematology
https://www.readbyqxmd.com/read/21776882/myeloprolipherative-disorder-type-chronic-myeloid-leukemia-eosinophilic-form
#18
Aida Arnautovic-Custovic, Samira Hasic, Emina Kopic, Azra Jahic, Svetlana Jovic
Chronic eosinophilic leukemia (CEL) is a very rare form of leucemia in the western world. Adequate response is seldomly achieved after treatment with corticosteroids, interferon-alfa (INF-alfa) and medications containing hydroxi-urea (Litalir). The study presents a patient with CEL with no initial therapeutic response to the use of corticosteroids, INF-alfa and hydroxy-urea, and with neither clinical nor hematological response. After setting a diagnosis of CEL, patient was ordinated Imatinib (Glivec tabbletes) in a daily dose of 200 mg...
2011: Medicinski Arhiv
https://www.readbyqxmd.com/read/21025159/acute-lympathic-leucemia-occurring-during-pregnancy
#19
A S BRIGHT, J G HAYES
No abstract text is available yet for this article.
May 1946: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/21024770/lymphocytoma-leucemia-in-a-cow-report-of-case
#20
D E JASPER, J H SAUTTER, W A MALMQUIST
No abstract text is available yet for this article.
May 1946: Journal of the American Veterinary Medical Association
keyword
keyword
43893
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"